Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Antiaging Quantum Living Inc AAQL

Antiaging Quantum Living Inc. is an investment holding company. It focuses on Website development, maintenance and online business advertisement. Its primary business operations are conducted through its subsidiaries AAQL Inc., AAQL HK Limited, Antiaging Doctor Hangzhou Holding LTD (Dao Ling Doctor Hangzhou), Dao Ling Doctor (Zhejiang) Health Management Limited (Dao Ling Doctor Zhejiang), and... see more

Recent & Breaking News (OTCPK:AAQL)

Achillion to Present at the Two Upcoming Healthcare Conferences

Globe Newswire September 6, 2013

Achillion Reports Second Quarter and Six Month 2013 Financial Results

Globe Newswire August 7, 2013

Technical Stock Chart Analysis of Breakout Medical Device Company

Accesswire August 6, 2013

BBRY, MNKD, GTAT and ACHN added to NASDAQ Active Stock Watch List at GSR

Accesswire August 5, 2013

Medical Device Company Granted European Patent to Remove Viruses from Blood

Accesswire July 26, 2013

Updates on Ongoing Clinical Trials and Retail Expansions - Research Report on Achillion, Medivation, ACADIA, Halozyme, and Charles River Laboratories

PR Newswire July 5, 2013

Five Star Equities Issues New Research Reports on ACHN, AFOP, DVA and ZEP

Accesswire July 3, 2013

Achillion Provides Update on Sovaprevir Development Program

Globe Newswire July 1, 2013

Wall Street Fundamentals Releases New In-Depth Stock Reports on ACAD, ACHN, CLDX and KERX

Accesswire June 24, 2013

Achillion to Present at the Wells Fargo 2013 Healthcare Conference

Globe Newswire June 12, 2013

Drug Findings, Applications and Approvals Strengthen Prospects - Research Report on Health Management Associates, Boston Scientific, Endo Health, Achillion Pharmaceuticals, and Cardiovascular Systems

PR Newswire June 5, 2013

Achillion Nominates ACH-3422 as Nucleotide for the Treatment of Chronic HCV

Globe Newswire May 30, 2013

Achillion Names Milind Deshpande, Ph.D., as President, Chief Executive Officer, Following Announced Retirement of Michael Kishbauch

Globe Newswire May 28, 2013

Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team

Globe Newswire May 15, 2013

Achillion to Present at Three Upcoming Investor Conferences

Globe Newswire May 9, 2013

Achillion Reports First Quarter 2013 Financial Results

Globe Newswire May 7, 2013

Achillion Presents New Data on ACH-3102 to Treat Hepatitis C at the International Liver Congress

Globe Newswire April 23, 2013

Achillion Announces Updated Phase 2 Results Including Early Sustained Virologic Response on ACH-3102 Plus Ribavirin in Genotype 1b Treatment-Naive Hepatitis C Patients

Globe Newswire April 23, 2013

Achillion Initiates Phase 2 Interferon-Free Trial of Sovaprevir and ACH-3102 for Genotype 1 HCV

Globe Newswire April 16, 2013

New Programs Designed to Speed Up Approval Process a Key Factor in Biotech Industry's Growth in 2012

Marketwired March 7, 2013